Citations

Citations to this article as recorded by  

• Research on the Histological Features and Pathological Types of Gastric Adenocarcinoma With Mucinous Differentiation
  Nian-Long Meng, Yang-kun Wang, Hai-Li Wang, Jun-Ling Zhou, Su-nan Wang
  Frontiers in Medicine.2022;[Epub]     CrossRef
• Clinicopathologic characteristics of HER2-positive pure mucinous carcinoma of the breast
  Yunjeong Jang, Hera Jung, Han-Na Kim, Youjeong Seo, Emad Alsharif, Seok Jin Nam, Seok Won Kim, Jeong Eon Lee, Yeon Hee Park, Eun Yoon Cho, Soo Youn Cho
  Journal of Pathology and Translational Medicine.2020; 54(1): 95.     CrossRef
• Human Epidermal Growth Factor Receptor 2-positive Mucinous Carcinoma with Signet Ring Cell Differentiation, Which Showed Complete Response after Neoadjuvant Chemotherapy
  Yunjeong Jang, Eun Yoon Cho, Soo Youn Cho
  Journal of Breast Cancer.2019; 22(2): 336.     CrossRef

Citations

Citations to this article as recorded by  

• Good practice: The experiences with the utilization of residual cancer burden—A single institution study
  Anita Sejben, Fanni Hegedűs, Szintia Almási, Márton Berta, Orsolya Oláh‐Németh, Tamás Zombori
  Thoracic Cancer.2023; 14(11): 963.     CrossRef
• Assessing the Correlation of Rate of Pathological Complete Response and Outcome in Post Neoadjuvant Chemotherapy Setting and Molecular Subtypes of Breast Cancer
  Ahmad Omair, Abdulmohsen Alkushi, Ghaida Alamri, Talal Almojel, Sara Alsadun, Emad Masuadi, Haitham Arabi, Amin E Mohamed, Omalkhair A Abulkhair
  Cureus.2023;[Epub]     CrossRef
• Compression OCT-elastography combined with speckle-contrast analysis as an approach to the morphological assessment of breast cancer tissue
  Anton A. Plekhanov, Ekaterina V. Gubarkova, Marina A. Sirotkina, Alexander A. Sovetsky, Dmitry A. Vorontsov, Lev A. Matveev, Sergey S. Kuznetsov, Alexandra Y. Bogomolova, Alexey Y. Vorontsov, Alexander L. Matveyev, Sergey V. Gamayunov, Elena V. Zagaynova,
  Biomedical Optics Express.2023; 14(6): 3037.     CrossRef
• Ambiguity-aware breast tumor cellularity estimation via self-ensemble label distribution learning
  Xiangyu Li, Xinjie Liang, Gongning Luo, Wei Wang, Kuanquan Wang, Shuo Li
  Medical Image Analysis.2023; 90: 102944.     CrossRef
• Concurrent Chemo-radiation As a Means of Achieving Pathologic Complete Response in Triple Negative Breast Cancer
  Maryam Nemati Shafaee, Shalini Makawita, Bora Lim, Matthew J Ellis, Michelle S Ludwig
  Clinical Breast Cancer.2022; 22(4): e536.     CrossRef
• Pathology after neoadjuvant treatment – How to assess residual disease
  Giuseppe Viale, Nicola Fusco
  The Breast.2022; 62: S25.     CrossRef
• Efficacy Evaluation of Neoadjuvant Chemotherapy in Breast Cancer by MRI
  Yongguang Liu, Mingxiang Wu, Wenyong Tan, Jingshan Gong, Jie Ma, Mohammad Farukh Hashmi
  Contrast Media & Molecular Imaging.2022; 2022: 1.     CrossRef
• Predictive Role of Soluble IL-6R, TNF-R1/2, and Cell Adhesion Molecules Serum Levels in the Preoperative and Adjuvant Therapy in Women with Nonmetastatic Breast Cancer: A Preliminary Study
  Weronika Bulska-Będkowska, Paulina Czajka-Francuz, Sylwia Cisoń-Jurek, Aleksander J. Owczarek, Tomasz Francuz, Jerzy Chudek
  Journal of Interferon & Cytokine Research.2022; 42(11): 557.     CrossRef
• The prognostic role of lymph node ratio in breast cancer patients received neoadjuvant chemotherapy: A dose-response meta-analysis
  Jinzhao Liu, Yifei Li, Weifang Zhang, Chenhui Yang, Chao Yang, Liang Chen, Mingjian Ding, Liang Zhang, Xiaojun Liu, Guozhong Cui, Yunjiang Liu
  Frontiers in Surgery.2022;[Epub]     CrossRef
• The Role of miR-375-3p, miR-210-3p and Let-7e-5p in the Pathological Response of Breast Cancer Patients to Neoadjuvant Therapy
  Lorena Alexandra Lisencu, Andrei Roman, Simona Visan, Eduard-Alexandru Bonci, Andrei Pașca, Emilia Grigorescu, Elena Mustea, Andrei Cismaru, Alexandru Irimie, Cosmin Lisencu, Loredana Balacescu, Ovidiu Balacescu, Oana Tudoran
  Medicina.2022; 58(10): 1494.     CrossRef
• Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer
  Elisa Agostinetto, Flavia Jacobs, Véronique Debien, Alex De Caluwé, Catalin-Florin Pop, Xavier Catteau, Philippe Aftimos, Evandro de Azambuja, Laurence Buisseret
  Cancers.2022; 14(21): 5467.     CrossRef
• Tumor Microenvironment in Breast Cancer—Updates on Therapeutic Implications and Pathologic Assessment
  Joshua J. Li, Julia Y. Tsang, Gary M. Tse
  Cancers.2021; 13(16): 4233.     CrossRef
• SPIE-AAPM-NCI BreastPathQ challenge: an image analysis challenge for quantitative tumor cellularity assessment in breast cancer histology images following neoadjuvant treatment
  Nicholas Petrick, Shazia Akbar, Kenny H. Cha, Sharon Nofech-Mozes, Berkman Sahiner, Marios A. Gavrielides, Jayashree Kalpathy-Cramer, Karen Drukker, Anne L. Martel, for the BreastPathQ Challenge Group
  Journal of Medical Imaging.2021;[Epub]     CrossRef
• Diagnostic performance of digital breast tomosynthesis for predicting response to neoadjuvant systemic therapy in breast cancer patients: A comparison with magnetic resonance imaging, ultrasound, and full-field digital mammography
  Ryusuke Murakami, Hitomi Tani, Shinichiro Kumita, Nachiko Uchiyama
  Acta Radiologica Open.2021; 10(12): 205846012110637.     CrossRef
• Los márgenes
  Laia Bernet, María Angeles Montero Fernández
  Revista de Senología y Patología Mamaria.2021; 34: S25.     CrossRef
• Neoadjuvant chemotherapy in non‐metastatic breast cancer: a study on practice trends in a regional cancer treatment service
  Edmond Ang, Navin Wewala, Rebecca Carroll, Garry Forgeson, Malcolm Anderson, Jennifer Fernando, Jody Jordan, Richard Isaacs
  Internal Medicine Journal.2020; 50(3): 315.     CrossRef
• Examination of Tumor Regression Grading Systems in Breast Cancer Patients Who Received Neoadjuvant Therapy
  Anita Sejben, Renáta Kószó, Zsuzsanna Kahán, Gábor Cserni, Tamás Zombori
  Pathology & Oncology Research.2020; 26(4): 2747.     CrossRef
• Integrating evolutionary dynamics into cancer therapy
  Robert A. Gatenby, Joel S. Brown
  Nature Reviews Clinical Oncology.2020; 17(11): 675.     CrossRef
• Assessing the accuracy of conventional gadolinium‐enhanced breast MRI in measuring the nodal response to neoadjuvant chemotherapy (NAC) in breast cancer
  Lisa Christine Murphy, Edel Marie Quinn, Zeeshan Razzaq, Claire Brady, Vicki Livingstone, Lorna Duddy, Josephine Barry, Henry Paul Redmond, Mark Anthony Corrigan
  The Breast Journal.2020; 26(11): 2151.     CrossRef
• Early prediction of neoadjuvant chemotherapy response for advanced breast cancer using PET/MRI image deep learning
  Joon Ho Choi, Hyun-Ah Kim, Wook Kim, Ilhan Lim, Inki Lee, Byung Hyun Byun, Woo Chul Noh, Min-Ki Seong, Seung-Sook Lee, Byung Il Kim, Chang Woon Choi, Sang Moo Lim, Sang-Keun Woo
  Scientific Reports.2020;[Epub]     CrossRef
• Patterns of Regression in Breast Cancer after Primary Systemic Treatment
  Tamás Zombori, Gábor Cserni
  Pathology & Oncology Research.2019; 25(3): 1153.     CrossRef
• The Role of Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio in Predicting Neoadjuvant Chemotherapy Response in Breast Cancer
  Hee Yeon Kim, Tae Hyun Kim, Hye Kyoung Yoon, Anbok Lee
  Journal of Breast Cancer.2019; 22(3): 425.     CrossRef
• Higher underestimation of tumour size post-neoadjuvant chemotherapy with breast magnetic resonance imaging (MRI)—A concordance comparison cohort analysis
  Wen-Pei Wu, Hwa-Koon Wu, Chih-Jung Chen, Chih-Wie Lee, Shou-Tung Chen, Dar-Ren Chen, Chen-Te Chou, Chi Wei Mok, Hung-Wen Lai, Pascal A. T. Baltzer
  PLOS ONE.2019; 14(10): e0222917.     CrossRef
• Multimodal image-guided surgery of HER2-positive breast cancer using [111In]In-DTPA-trastuzumab-IRDye800CW in an orthotopic breast tumor model
  Marion M. Deken, Desirée L. Bos, Willemieke S. F. J. Tummers, Taryn L. March, Cornelis J. H. van de Velde, Mark Rijpkema, Alexander L. Vahrmeijer
  EJNMMI Research.2019;[Epub]     CrossRef
• Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer
  Ida Skarping, Daniel Förnvik, Hanna Sartor, Uffe Heide-Jørgensen, Sophia Zackrisson, Signe Borgquist
  BMC Cancer.2019;[Epub]     CrossRef
• ALDH1 and tumor infiltrating lymphocytes as predictors for neoadjuvant chemotherapy response in breast cancer
  Anbok Lee, Kyu Yeoun Won, Sung-Jig Lim, Sun Young Cho, Sang-Ah Han, SaeGwang Park, Jeong-Yoon Song
  Pathology - Research and Practice.2018; 214(5): 619.     CrossRef
• Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer
  Yunju Kim, Sung Hun Kim, Byung Joo Song, Bong Joo Kang, Kwang-il Yim, Ahwon Lee, Yoonho Nam
  Korean Journal of Radiology.2018; 19(4): 682.     CrossRef
• Outcomes of neoadjuvant and adjuvant chemotherapy in stage 2 and 3 non-small cell lung cancer: an analysis of the National Cancer Database
  Matthew MacLean, Xin Luo, Shidan Wang, Kemp Kernstine, David E. Gerber, Yang Xie
  Oncotarget.2018; 9(36): 24470.     CrossRef
• Automatic cellularity assessment from post‐treated breast surgical specimens
  Mohammad Peikari, Sherine Salama, Sharon Nofech‐Mozes, Anne L. Martel
  Cytometry Part A.2017; 91(11): 1078.     CrossRef
• The importance of tissue confirmation of metastatic disease in patients with breast cancer: lesson from a brain metastasis case
  Jingxian Ding, Pinghua Hu, Jun Chen, Xiaobo Wu, Yali Cao
  Oncoscience.2016; 3(9-10): 268.     CrossRef

This paper reports a case of low-grade adenosquamous carcinoma (LGASC) arising in a 69-year-old woman, who presented with a 1-cm palpable mass on her right breast. Core needle biopsy diagnosed the mass as a fibroadenoma. After six months, the mass increased in size, and the patient received subsequent mammotome excision. On microscopic examination, bland-looking small glands were infiltrating into the fibrotic stroma with lymphocytic infiltrates at the periphery. Hematoxylin and eosin staining revealed relatively easily detectable myoepithelial cells along the outside in each of the glandular structures with variable degrees of squamous metaplasia. Based on histologic features, the patient was diagnosed with LGASC. LGASC is a rare variant of metaplastic carcinoma, which is characterized by a favorable prognosis. Due to the bland cytology and presence of myoepithelial cells, LGASC can be misdiagnosed as benign lesion. Additionally, inconsistent expression of myoepithelial markers could aid the diagnosis of LGASC.

Citations

Citations to this article as recorded by  

• High rate of PIK3CA mutations but no TP53 mutations in low‐grade adenosquamous carcinoma of the breast
  Guillaume Bataillon, Laetitia Fuhrmann, Elodie Girard, Emanuelle Menet, Marick Laé, Mathieu Capovilla, Isabelle Treilleux, Laurent Arnould, Frederique Penault‐Llorca, Roman Rouzier, Caterina Marchiò, Ivan Bieche, Anne Vincent‐Salomon
  Histopathology.2018; 73(2): 273.     CrossRef
• Low-grade Adenosquamous Carcinoma Coexisting with Sclerosing Adenosis of the Breast: A Case Report
  Ryoko Oi, Ichiro Maeda, Yoshio Aida, Yukari Yabuki, Toru Nishikawa, Yoshihide Kanemaki, Koichiro Tsugawa, Masayuki Takagi
  Journal of St. Marianna University.2017; 8(1): 31.     CrossRef
• Low-grade Adenosquamous Carcinoma of the Breast
  Haruko SAKAMOTO, Akihiko SHIMANA, Hideaki HORI, Kouki TOKUDA, Hitoshi TSUBOUCHI, Miki TAKENAKA, Rin YAMAGUCHI
  Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association).2017; 78(9): 1983.     CrossRef
• Small Glandular Proliferations of the Breast With Absent or Attenuated Myoepithelial Reactivity by Immunohistochemistry: A Review Focusing on the Differential Diagnosis and Interpretative Pitfalls
  Paula S. Ginter, Sandra J. Shin, Timothy M. D'Alfonso
  Archives of Pathology & Laboratory Medicine.2016; 140(7): 651.     CrossRef
• Bilateral synchronous low-grade adenosquamous carcinoma of the breast: A Case report with review of the current literature
  J.L. Senger, P. Meiers, R. Kanthan
  International Journal of Surgery Case Reports.2015; 14: 53.     CrossRef
• A Nation-Wide Cancer Registry-Based Study of Adenosquamous Carcinoma in Taiwan
  Yuan-Tzu Lan, Kuo-Hung Huang, Chien-An Liu, Ling-Chen Tai, Ming-Huang Chen, Yee Chao, Anna Fen-Yau Li, Shih-Hwa Chiou, Yi-Ming Shyr, Chew-Wun Wu, Wen-Liang Fang, Sheng-Nan Lu
  PLOS ONE.2015; 10(10): e0139748.     CrossRef

Low-grade cribriform cystadenocarcinoma (LGCCC) of the salivary gland is a rare tumor. We report the cytologic features and histologic correlation of a patient with LGCCC. A 57-year-old man had a hardly palpable, nontender mass in the right cheek area followed over nine months. Radiologic analysis revealed a 1.2 cm multiseptated, cystic, solid nodule in an anterior superficial lobe of the right parotid gland. Fine-needle aspiration cytology revealed many irregular overlapping sheets or clusters of ductal epithelial cells forming solid, pseudopapillary, and cribriform architectures. Nuclei of the tumor cells revealed inconspicuous atypia with minimal size variation. On the basis of these findings, we confirmed a diagnosis of ductal epithelial proliferative lesion, favoring neoplasm, with uncertain malignant potential. Tumor excision was performed, revealing a tiny multicystic nodule (0.7 cm). Histopathologically, this tumor showed the characteristic morphology of LGCCC. This is the first report of cytomorphological findings of LGCCC in Korea.

Citations

Citations to this article as recorded by  

• Duct tales of a parotid gland swelling
  Swati Raj, Monika Singh, Mamta Gupta, Naveen Thapliyal
  Cytojournal.2023; 20: 22.     CrossRef
• Salivary Gland Intraductal Carcinoma: How Do 183 Reported Cases Fit Into a Developing Classification
  Lester D.R. Thompson, Justin A. Bishop
  Advances in Anatomic Pathology.2023; 30(2): 112.     CrossRef
• Intraductal carcinoma of the parotid gland
  Yukiya HIRATA, Kayoko HIGUCHI, Toshitaka NAGAO, Yoko ZUKERAN, Takao KINJO, Naoki WADA
  The Journal of the Japanese Society of Clinical Cytology.2022; 61(6): 431.     CrossRef
• Intraductal carcinomas of the salivary glands: systematic review and classification of 93 published cases
  Andrea Palicelli
  APMIS.2020; 128(3): 191.     CrossRef
• What do we know about the cytological features of pure intraductal carcinomas of the salivary glands?
  Andrea Palicelli
  Cytopathology.2020; 31(3): 185.     CrossRef
• Diagnosing Recently Defined and Uncommon Salivary Gland Lesions in Limited Cellularity Specimens: Cytomorphology and Ancillary Studies
  Esther Diana Rossi, Zubair Baloch, William Faquin, Liron Pantanowitz
  AJSP: Reviews and Reports.2020; 25(5): 210.     CrossRef
• Low-grade intraductal carcinoma of salivary glands: A systematic review of this rare entity
  Francesco Giovacchini, Caterina Bensi, Stefano Belli, Maria Elena Laurenti, Martina Mandarano, Daniele Paradiso, Michele Giansanti, Antonio Tullio
  Journal of Oral Biology and Craniofacial Research.2019; 9(1): 96.     CrossRef
• The rare entity of cystadenocarcinoma (CAC) in parotid gland: A single-center experience
  Bing Guo, Yu-an Cao, Xingjun Qin, Chunyue Ma
  Journal of Cranio-Maxillofacial Surgery.2019; 47(5): 826.     CrossRef
• Cytopathology approach to rare salivary gland lesions with oncocytic features
  Siba El Hussein, Samer N. Khader
  Diagnostic Cytopathology.2019; 47(10): 1090.     CrossRef
• Unicystic high‐grade intraductal carcinoma of the parotid gland: cytological and histological description with clinic–pathologic review of the literature
  Andrea Palicelli, Paola Barbieri, Narciso Mariani, Paola Re, Stefania Galla, Raffaele Sorrentino, Francesca Locatelli, Nunzio Salfi, Guido Valente
  APMIS.2018; 126(9): 771.     CrossRef
• Low-grade cribriform cystadenocarcinoma arising from a minor salivary gland: a case report
  Masashi Kimura, Shinji Mii, Shinichi Sugimoto, Kosuke Saida, Shojiroh Morinaga, Masahiro Umemura
  Journal of Oral Science.2016; 58(1): 145.     CrossRef
• A Case of Cystadenocarcinoma Arising from Parotid Gland
  Jong Chul Hong, Tae Kyoung Koh, Min Gyoung Pak, Heon Soo Park
  Korean Journal of Otorhinolaryngology-Head and Neck Surgery.2016; 59(4): 300.     CrossRef
• Mammary analogue secretory carcinoma of parotid gland
  Atsuko NASU, Sakae HATA, Masaru FUJITA, Toyoko YAMAUCHI, Satoko NAKAMURA, Takehiro TANAKA, Kouichi ICHIMURA, Hiroyuki YANAI
  The Journal of the Japanese Society of Clinical Cytology.2016; 55(2): 112.     CrossRef

Mucinous cystadenocarcinoma (MCA) in the breast is a rare neoplasm. There have been 13 cases of primary breast MCA reported. The MCA presents as a large, partially cystic mass in postmenopausal woman with a good prognosis. The microscopic findings resemble those of ovarian, pancreatic, or appendiceal MCA. The aspiration findings showed mucin-containing cell clusters in the background of mucin and necrotic material. The cell clusters had intracytoplasmic mucin displacing atypical nuclei to the periphery. Histologically, the tumor revealed an abundant mucin pool with small floating clusters of mucin-containing tumor cells. There were also small cysts lined by a single layer of tall columnar mucinous cells, resembling those of the uterine endocervix. The cancer cells were positive for mucin (MUC) 5 and negative for MUC2 and MUC6. This mucin profile is different from ordinary mucinous carcinoma and may be a unique characteristic of breast MCA.

Citations

Citations to this article as recorded by  

• Mucinous cystadenocarcinoma of the breast harbours TRPS1 expressions and PIK3CA alterations
  Wei‐Yu Chen, Yu‐Hsuan Hu, Yu‐Hsin Tsai, Jen‐Fan Hang, Puay Hoon Tan, Chih‐Jung Chen
  Histopathology.2024; 84(3): 550.     CrossRef
• Pure mucinous adenocarcinoma of the breast with the rare lymphoplasmacytic infiltration: A case report with review of literature
  Yash Hasmukhbhai Prajapati, Vishal Bhabhor, Kahan Samirkumar Mehta, Mithoon Barot, Husen Boriwala, Mohamed Omar
  Clinical Case Reports.2024;[Epub]     CrossRef
• Mammary mucinous cystadenocarcinoma with long-term follow-up: molecular information and literature review
  Ting Lei, Yong Qiang Shi, Tong Bing Chen
  Diagnostic Pathology.2023;[Epub]     CrossRef
• Primary Mucinous Cystadenocarcinoma of the Breast Intermixed with Pleomorphic Invasive Lobular Carcinoma: The First Report of This Rare Association
  Federica Vegni, Nicoletta D’Alessandris, Angela Santoro, Giuseppe Angelico, Giulia Scaglione, Angela Carlino, Damiano Arciuolo, Michele Valente, Stefania Sfregola, Maria Natale, Alejandro Martin Sanchez, Valeria Masciullo, Gian Franco Zannoni, Antonino Mu
  Journal of Personalized Medicine.2023; 13(6): 948.     CrossRef
• Special Histologic Type and Rare Breast Tumors – Diagnostic Review and Clinico-Pathological Implications
  Benjamin Yongcheng Tan, Elaine Hsuen Lim, Puay Hoon Tan
  Surgical Pathology Clinics.2022; 15(1): 29.     CrossRef
• Mucinous cystadenocarcinoma of the breast: a new entity with broad differentials—a case report
  Kanwalpreet Kaur, Ashini Shah, Jahnvi Gandhi, Priti Trivedi
  Journal of the Egyptian National Cancer Institute.2022;[Epub]     CrossRef
• Mucinous carcinoma of the breast: distinctive histopathologic and genetic characteristics
  Minjung Jung
  Kosin Medical Journal.2022; 37(3): 176.     CrossRef
• Primary Mucinous Cystadenocarcinoma of the Breast: A Rare Case Report With Review of Literature
  Ekta Jain, Abhishek Kumar, Raajul Jain, Shivani Sharma
  International Journal of Surgical Pathology.2021; 29(7): 740.     CrossRef
• Mucinous Cystadenocarcinoma of the Breast: Report of 2 Cases Including One With Long-Term Local Recurrence
  Anupma Nayak, Ira J. Bleiweiss, Kimberly Dumoff, Tawfiqul A. Bhuiya
  International Journal of Surgical Pathology.2018; 26(8): 749.     CrossRef
• Mucinous breast carcinoma with tall columnar cells
  N Tsoukalas, M Kiakou, M Tolia, ID Kostakis, M Galanopoulos, G Nakos, D Tryfonopoulos, G Kyrgias, G Koumakis
  The Annals of The Royal College of Surgeons of England.2018; 100(5): e132.     CrossRef
• Radiologic Findings of Primary Mucinous Cystadenocarcinoma of the Breast: A Report of Two Cases and a Literature Review
  Minjung Seong, Eun Young Ko, Boo-Kyung Han, Soo Youn Cho, Eun Yoon Cho, Se Kyung Lee, Jeong Eon Lee
  Journal of Breast Cancer.2016; 19(3): 330.     CrossRef
• Primary Mucinous Cystadenocarcinoma of the Breast with Endocervical-Like Mucinous Epithelium
  Dong-Liang Lin, Ji-Lin Hu, Shi-Hong Shao, Dong-Mei Sun, Ji-Gang Wang
  Breast Care.2013; 8(6): 445.     CrossRef

Rosai-Dorfman disease (RDD) can present in any anatomic site, but breast involvement is rarely reported. Recently, a relationship between RDD and IgG4-related sclerosing disease has been suggested. Here we report another case of RDD with overlapping features of IgG4-related sclerosing disease occurring in a right breast of a 62-year-old female. On microscopic examination, the mass demonstrated a characteristic zonal pattern of proliferation of large polygonal histiocytes and lymphoplasma cells with stromal fibrosis. Emperipolesis was observed in histiocytes with abundant cytoplasm, which showed immunoreactivity for S-100 protein and CD68; the diagnosis of RDD was made. Sheets of plasma cells in the fibrotic stroma demonstrated positive reactions for IgG and IgG4. The mean count of IgG4-positive plasma cells was 100.2/high power field, and the ratio of IgG4/IgG was 56.7%. Additional findings of stromal fibrosis and obliteration of preexisting breast lobules suggested overlapping features with IgG4-related sclerosing disease.

Citations

Citations to this article as recorded by  

• Pathology of IgG4-related sclerosing mastitis
  Polycarp Erivwo, Gulisa Turashvili
  Journal of Clinical Pathology.2021; 74(8): 475.     CrossRef
• Rosai–Dorfman Disease: Breast Involvement—Case Report and Literature Review
  George Iancu, Nicolae Gica, Laura Mihaela Mustata, Anca Maria Panaitescu, Danut Vasile, Gheorghe Peltecu
  Medicina.2021; 57(11): 1167.     CrossRef
• Sonographic features of Rosai‐Dorfman disease in the breast: A case report
  Gi W. Shin, Young M. Park, Young J. Heo, Jin W. Baek, Yoo J. Lee, Ji Y. Han, Hayoung Park
  Journal of Clinical Ultrasound.2020; 48(2): 108.     CrossRef
• Rosai-Dorfman Disease of the Breast With Variable IgG4+ Plasma Cells
  Jenny C. Hoffmann, Chieh-Yu Lin, Siddhartha Bhattacharyya, Olga K. Weinberg, Karen M. Chisholm, Michael Bayerl, Michael Cascio, Girish Venkataraman, Kimberly Allison, Megan Troxell, Chung-Che Chang, Adam Bagg, Tracy I. George, Dennis O’Malley, Robert S. O
  American Journal of Surgical Pathology.2019; 43(12): 1653.     CrossRef
• Rosai-Dorfman disease presenting as a breast mass
  Dai Ding*, Cai Qi, Vohra Nasreen A. , Wong Jan, Therien Zsuzsanna P. , Hewan-Lowe Karlene , Sutton Ann
  Archives of Pathology and Clinical Research.2019; 3(1): 008.     CrossRef
• Erdheim-Chester Disease Involving Lymph Nodes and Liver Clinically Mimicking Lymphoma: A Case Report
  Yeoun Eun Sung, Yoon Seo Lee, Jieun Lee, Kyo Young Lee
  Journal of Pathology and Translational Medicine.2018; 52(3): 183.     CrossRef
• Enfermedad de Rosai-Dorfman en mama de paciente masculino: una entidad rara
  Paola Iturralde Rosas-Priego, José Daniel Flores-Alatriste, Daniela Stuht López, Javier Gómez Pedroso-Rea, Cecilia Ortiz-de-Iturbide, Jorge Valenzuela-Tamariz, Manuel Ubiergo-García
  Revista de Senología y Patología Mamaria.2018; 31(2): 72.     CrossRef
• Increased Immunoglobulin G4-positive Plasma Cells in Lymphadenoma of the Salivary Gland: An Immunohistochemical Comparison Among Lymphoepithelial Lesions
  Jiyoon Kim, Joon Seon Song, Jong-Lyel Roh, Seung-Ho Choi, Soon Yuhl Nam, Sang Yoon Kim, Kyung-Ja Cho
  Applied Immunohistochemistry & Molecular Morphology.2018; 26(6): 420.     CrossRef
• IgG4-Related Sclerosing Disease of the Breast in a Male Patient
  Taisia Vitkovski, Galina S. Marder, Dominic A. Filardi, Ekta Gupta, Frank Breuer
  International Journal of Surgical Pathology.2017; 25(8): 711.     CrossRef
• Extranodal manifestation of Rosai-Dorfman disease in the breast tissue
  Qiao Zhou, Umer Ansari, Nandan Keshav, Fiona Davis, Maria Cundiff
  Radiology Case Reports.2016; 11(3): 125.     CrossRef
• Rosai-Dorfman Disease with Massive Cutaneous Nodule on the Shoulder and Back
  Han Ma, Yue Zheng, Guoxing Zhu, Jie Wu, Chun Lu, Wei Lai
  Annals of Dermatology.2015; 27(1): 71.     CrossRef
• IgG4-related disease of the breast: a systemic disease whose mammary manifestations mimic breast cancer
  Takuya Moriya, Hisashi Hirakawa, Maki Nagashima, Mitsuhiko Yasuda, Izo Kimijima
  International Cancer Conference Journal.2015; 4(2): 67.     CrossRef
• Primary Cutaneous Marginal IgG4 Lymphoma and Rosai–Dorfman's Disease Coexisting in Several Lesions of the Same Patient
  Salma Machan, Camino Medina, Socorro María Rodríguez-Pinilla, José M. Suárez-Peñaranda, Yolanda Castro, Paula Molés, Celia Requena, Carles Saus, Luis Requena, Carlos Santonja
  The American Journal of Dermatopathology.2015; 37(5): 413.     CrossRef
• A subset of Rosai–Dorfman disease cases show increased IgG4‐positive plasma cells: another red herring or a true association with IgG4‐related disease?
  Madhu P Menon, Moses O Evbuomwan, Juan Rosai, Elaine S Jaffe, Stefania Pittaluga
  Histopathology.2014; 64(3): 455.     CrossRef
• Freiburg Neuropathology Case Conference: A Partially Calcified, Dura-based Tumour of the Frontal Lobe
  C. A. Taschner, O. Staszewski, R. Jabbarli, A. Keuler, M. Prinz
  Clinical Neuroradiology.2013; 23(1): 63.     CrossRef

Citations

Citations to this article as recorded by  

• The role of histopathologic testing on apocrine carcinoma of the breast
  Burak Ilhan, Selman Emiroğlu, Rustu Türkay, Rıdvan Ilhan
  Current Problems in Cancer.2020; 44(2): 100501.     CrossRef
• Cancer du sein triple négatif exprimant le récepteur aux androgènes : de la biologie à la thérapeutique
  Thomas Grellety
  Bulletin du Cancer.2020; 107(4): 506.     CrossRef
• Triple‐negative apocrine carcinoma: A rare pathologic subtype with a better prognosis than other triple‐negative breast cancers
  Cletus A. Arciero, Albert H. Diehl, Yuan Liu, Qin Sun, Theresa Gillespie, Xiaoxian Li, Preeti Subhedar
  Journal of Surgical Oncology.2020; 122(6): 1232.     CrossRef
• Apocrine lesions of the breast: part 2 of a two-part review. Invasive apocrine carcinoma, the molecular apocrine signature and utility of immunohistochemistry in the diagnosis of apocrine lesions of the breast
  Clare D'Arcy, Cecily M Quinn
  Journal of Clinical Pathology.2019; 72(1): 7.     CrossRef
• Enhancing Abiraterone Acetate Efficacy in Androgen Receptor–positive Triple-negative Breast Cancer: Chk1 as a Potential Target
  Thomas Grellety, Celine Callens, Elodie Richard, Adrien Briaux, Valérie Vélasco, Marina Pulido, Anthony Gonçalves, Pierre Gestraud, Gaetan MacGrogan, Hervé Bonnefoi, Bruno Cardinaud
  Clinical Cancer Research.2019; 25(2): 856.     CrossRef
• A clinicopathologic study of invasive apocrine carcinoma of the breast: A single-center experience
  Denira Imamovic, Nurija Bilalovic, Faruk Skenderi, Vanesa Beslagic, Timur Ceric, Berisa Hasanbegovic, Semir Beslija, Semir Vranic
  The Breast Journal.2018; 24(6): 1105.     CrossRef
• Dose invasive apocrine adenocarcinoma has worse prognosis than invasive ductal carcinoma of breast: evidence from SEER database
  Ning Zhang, Hanwen Zhang, Tong Chen, Qifeng Yang
  Oncotarget.2017; 8(15): 24579.     CrossRef
• Pure Apocrine Carcinomas Represent a Clinicopathologically Distinct Androgen Receptor–Positive Subset of Triple-Negative Breast Cancers
  Anne M. Mills, Chelsea E. Gottlieb, Scott M. Wendroth, Christiana M. Brenin, Kristen A. Atkins
  American Journal of Surgical Pathology.2016; 40(8): 1109.     CrossRef
• Androgen Receptor: A Complex Therapeutic Target for Breast Cancer
  Ramesh Narayanan, James Dalton
  Cancers.2016; 8(12): 108.     CrossRef
• Early versus late distant metastasis and adjuvant chemotherapy alone versus both radiotherapy and chemotherapy in molecular apocrine breast cancer
  Xiaozhen Liu, Yang Yang, Xiaolong Feng, Honghong Shen, Jian Liu, Xia Liu, Yun Niu
  Oncotarget.2016; 7(31): 48905.     CrossRef
• Molecular and diagnostic features of apocrine breast lesions
  Pavel Gromov, Jaime A Espinoza, Irina Gromova
  Expert Review of Molecular Diagnostics.2015; 15(8): 1011.     CrossRef
• Prevalencia de receptores androgénicos en el cáncer de mama
  Claudia Janeth Rodríguez-Silva, José Luis González-Vela, Ascary Alcides Velázquez-Pacheco
  Gaceta Mexicana de Oncología.2015; 14(3): 135.     CrossRef